The 10th annual Amsterdam Immunogenicity and Tolerance Seminar will take place on Friday, November 8th, 2024 from 9:30am – 7:30 pm. All events (including a networking session with beer, wine and snacks!) will be located at the Hilton Apollolaan in Amsterdam.
About the Amsterdam Immunogenicity & Tolerance Seminar:
Now in its 10th year, The Amsterdam Immunogenicity & Tolerance Seminar will showcase talks from expert biologics and vaccine developers from industry and academia highlighting how immunogenicity and tolerance have played a role in their recent work.
Speakers for this year include visionaries from Leiden University Medical Centre, Pfizer, Inc., Utrecht University, EpiVax, Inc., and more. Topics will cover updates on the preclinical and clinical development of tolerance-inducing therapies for autoimmune diseases, immunogenicity assessment strategies and case studies for selection of optimal biologics and vaccines, and updates on how to address hyporesponsiveness and off-target effects of vaccines.
In addition to the talks, there will be networking opportunities, poster presentations, and more.
As a leader in the field of preclinical immunogenicity assessment, design, and optimization of biologics and vaccines, in addition to a developer of a tolerance-inducing therapy, EpiVax hosts this seminar to connect with Europe-based collaborators and to bring industry and academic experts together to share new ideas and present research updates in the space.
Please note: This is an in-person event with no options for virtual attendance.
Are you interested in presenting a poster at the conference? Submit a one page abstract here.
Check out past year’s AIT Seminars:
2023 Amsterdam Immunogenicity & Tolerance Seminar
2021 Amsterdam Immunogenicity & Tolerance Seminar
More information: https://epivax.com/amsterdam-immunogeniity-tolerance-24/